Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial

  • Aliaksandr Skrahin, Raija K Ahmed, Giovanni Ferrara, Lalit Rane, Thomas Poiret, Yanina Isaikina, Alena Skrahina, Alimuddin Zumla, Markus J Maeurer
  • The Lancet Respiratory Medicine, February 2014, Elsevier
  • DOI: 10.1016/s2213-2600(13)70234-0

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Giovanni Ferrara